Tanım

The global coronary stents market is poised to grow by US$ 1.8 sırasında milyar 2022-2028, CAGR'da ilerliyor 4.2% tahmin dönemi boyunca, veri ve analiz şirketi StratejiHelix'e göre.

Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2018-2021 ve tahmin 2028 covering key market aspects like sales value for coronary stents. The global coronary stents market is segmented on the basis of product, biomaterial, end user, ve bölge. Ürüne göre, the global coronary stents market has been segmented into bare metal stents (BMS), bioabsorbable stents (BAS), drug eluting stents (DES). Based upon biomaterial, the global coronary stents market is categorized into metallic biomaterials, natural biomaterials, polymeric biomaterials. On the basis of end user, the global coronary stents market has been segmented into ambulatory surgical centers (ASC'ler), hospitals. coğrafi olarak, the global coronary stents market is segmented into Asia Pacific, Avrupa, Kuzey Amerika, Dünyanın Geri Kalanı (RoW).

The global coronary stents market is highly competitive. The prominent players operating in the global coronary stents market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & ortak. KİLOGRAM, Boston Scientific Corporation, Cook Group Incorporated, Lepu Medical Technology (Beijing) ortak. Ltd., Medtronic plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corp., Sahajanand Medical Technologies Pvt Ltd, Shandong Blue Sail Plastic & Rubber Co. Ltd.. (Biosensors International Group Ltd.), Terumo Corporation, Translumina Therapeutics LLP, Vascular Concepts Ltd. Competitive landscape gives a description of the competitive nature of the global coronary stents market and a description of the leading companies. Son yıllarda piyasayı şekillendiren önemli finansal anlaşmalar belirlendi.

Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the coronary stents market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.

Rapor Kapsamı

Ürün: bare metal stents (BMS), bioabsorbable stents (BAS), drug eluting stents (DES)
Biomaterial: metallic biomaterials, natural biomaterials, polymeric biomaterials
End user: ambulatory surgical centers (ASC'ler), hospitals
Bölge: Asya Pasifik, Avrupa, Kuzey Amerika, Dünyanın Geri Kalanı (RoW)
Dikkate alınan yıllar: bu rapor dönemi kapsamaktadır 2018 ile 2028
Adı geçen şirket: Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & ortak. KİLOGRAM, Boston Scientific Corporation, Cook Group Incorporated, Lepu Medical Technology (Beijing) ortak. Ltd., Medtronic plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corp., Sahajanand Medical Technologies Pvt Ltd, Shandong Blue Sail Plastic & Rubber Co. Ltd.. (Biosensors International Group Ltd.), Terumo Corporation, Translumina Therapeutics LLP, Vascular Concepts Ltd.

Paydaşlar için Temel Faydalar

– Get a comprehensive picture of the global coronary stents market
– Büyüme sektörlerini ve yatırım eğilimlerini belirleyin

İçindekiler

Parça 1. giriiş
– Çalışmanın kapsamı
– Çalışma periyodu
– Coğrafik kapsam
– Araştırma metodolojisi
Parça 2. Coronary stents market overview
Parça 3. Market breakdown by product
– Bare metal stents (BMS)
– Bioabsorbable stents (BAS)
– Drug eluting stents (DES)
Parça 4. Market breakdown by biomaterial
– Metallic biomaterials
– Natural biomaterials
– Polymeric biomaterials
Parça 5. Market breakdown by end user
– Ambulatory surgical centers (ASC'ler)
– Hastaneler
Parça 6. Market breakdown by region
– Asya Pasifik
– Avrupa
– Kuzey Amerika
– Dünyanın Geri Kalanı (RoW)
Parça 7. Anahtar şirketler
– Abbott Laboratories
– B. Braun Melsungen AG
– Biotronik SE & ortak. KİLOGRAM
– Boston Scientific Corporation
– Cook Group Incorporated
– Lepu Medical Technology (Beijing) Şti., Ltd..
– Medtronic plc
– Meril Life Sciences Pvt. Ltd..
– MicroPort Scientific Corp.
– Sahajanand Medical Technologies Pvt Ltd
– Shandong Blue Sail Plastic & Rubber Co., Ltd.. (Biosensors International Group Ltd.)
– Terumo Corporation
– Translumina Therapeutics LLP
– Vascular Concepts Ltd.
StratejiHelix Hakkında
Sorumluluk reddi beyanı